AK1780
N/A
Report date: 2022/12/23 17:57:05
Base Information
Drug NameAK1780
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRaqualia Pharma IncAsahi Kasei Pharma Corp
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And CompanyAsahi Kasei Pharma Corp
Inactive CompaniesRaqualia Pharma Inc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A